Dose-normalized plasma concentration-time curves of a mAb following subcutaneous (SC) and intravenous (IV) administration to cynomolgus monkeys (mean ±

Slides:

Advertisements

Similar presentations

A service provided to medicine by Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License Pharmacokinetics.

Advertisements

Pharmaceutics I Introduction 1. Pharmaceutics Pharmaceutics is the science of dosage form design. There are many chemicals with known pharmacological.

Pharmacokinetics a. route of administration b. absorption and elimination Pharmacodynamics a. dose-effect curve b. therapeutic index c. ligand binding.

Pharmacology I BMS 242 Lecture I (Continued) Introduction; Scope of Pharmacology Routes of Drug Administration Dr. Aya M. Serry 2015/2016.

CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.

Pharmaceutics I صيدلانيات 1 Unit 2 Route of Drug Administration

CHAPTER 7 ABSORPTION KINETICS.

1 Pharmacokinetics: Introduction Dr Mohammad Issa.

Study Aids Anki Flash cards – Content that you need to know for the tests. MS Excel sheet with Calculations.

415 PHT Plasma Level – Time Curve

Drug Response Relationships

Comparative preclinical drug metabolism and pharmacokinetic evaluation of novel 4- aminoquinoline anti-malarials Charles B. Davis, Ramesh Bambal, Ganesh.

From: Insidious Intoxication After Morphine Treatment in Renal Failure: Delayed Onset of Morphine-6-glucuronide Action Anesthes. 2000;92(5):1473. Figure.

Volume 9, Issue 8, Pages (August 2017)

Plasma drug concentration-time profiles after IV infusion

Applications of Pharmacokinetics

The 3-compartment pharmacokinetic model

Figure 1. TAK-448 structure (A) and effect on the hypothalamic-pituitary-gonadal axis (B). At the normal physiological state, GnRH pulses in the hypothalamus.

Introduction; Scope of Pharmacology Routes of Drug Administration

Pharmacokinetics. Pharmacokinetics Oral administration Blood concentration after oral administration Cmax Concentration Concentration tmax Time Time.

From: A Simulation Study of Common Propofol and Propofol-Opioid Dosing Regimens for Upper Endoscopy:Implications on the Time Course of Recovery Anesthes.

Orientation to Pharmacology

Comparison of the model incorporating daily dose to that incorporating Cmax. Comparison of the model incorporating daily dose to that incorporating Cmax.

Effects of cytokines on P450 mRNA expression in human hepatocytes.

The context-sensitive half-times for commonly used intravenous anesthetic drugs. [Reproduced from Reves JG, Glass PSA, Lubarsky DA, McEvoy MD, and Martinez-Ruiz.

administration (single dose, 5 mg) in six healthy male volunteers.

Representative radio-HPLC chromatograms for individual pooled methanolic fecal extracts for periods of maximum recovery of radioactivity after dosing of.

HPLC tracings of resveratrol (RV) and its major sulfate conjugates M4/M5 in the plasma from three subjects. HPLC tracings of resveratrol (RV) and its major.

Total ion current-EMS chromatograms of SB939 and its metabolites after incubation in liver microsomal fractions for 60 min at a concentration of 50 μM.

Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy Ingo Roehl, Stephan Seiffert, Celia Brikh, Jonathan.

Anti-factor IXa/X bispecific antibody ACE910 prevents joint bleeds in a long-term primate model of acquired hemophilia A by Atsushi Muto, Kazutaka Yoshihashi,

Structure of solid lipid nanoparticles (SLNs).

The three primary ADC components that determine which cells are targeted (antibody), how the drug is released (linker/trigger), and the mechanism of action.

Pharmaceutics I Introduction 1. Pharmaceutics Pharmaceutics is the science of dosage form design. There are many chemicals with known pharmacological.

Model B. The melatonin-produced increase in extracellular dopamine concentration in the striatum is prevented by the CYP2D inhibitor propafenone in pargyline-pretreated.

Cytotoxic activities of polymer micelles containing CFZ in H460 (A) and select micelle formulations in RPMI-8226 (B) cell lines. Cytotoxic activities of.

Cytotoxic effects of PM1 and PM2 empty particle controls and coincubation of CFZ with empty particles tested in H460 (A) and RPMI-8226 (B) cells. Cytotoxic.

Geometric mean concentration-time profiles of (A) racemic BUP, R-BUP, and S-BUP; (B) racemic OHBUP, RR-OHBUP, and SS-OHBUP; (C) racemic ERY, SR-ERYHBUP,

The additive model assumes unspecific effects of equal size in both the placebo and drug arm or groups of studies or experiments. The additive model assumes.

Jennifer H. Huang, MD, Rachel Sunstrom, PA, Myrna Y

Voriconazole concentrations and outcome of invasive fungal infections

Pharmacokinetic Evaluation of the Drug Interaction between Intravenous Itraconazole and Intravenous Tacrolimus or Intravenous Cyclosporin A in Allogeneic.

Postoperative intravenous morphine titration

The INFUSE-Morphine Study: Use of Recombinant Human Hyaluronidase (rHuPH20) to Enhance the Absorption of Subcutaneously Administered Morphine in Patients.

Comparison of the observed and calculated CLR values of taurine and GCDCA-S. Comparison of the observed and calculated CLR values of taurine and GCDCA-S.

Fig. 4. Clearance of 12-mer-1 from a nonhuman primate model.

F. Estelle R. Simons, MD, FRCPCa, Xiaochen Gu, PhDb, Keith J

Effects of gemfibrozil on the exposure (area under the plasma drug concentration-time curve) to different CYP2C8 substrate drugs. Effects of gemfibrozil.

Mean (SD) AMG 557 serum concentration–time profiles following single-ascending dose (SAD) (A) and multiple-ascending dose (MAD) (B) administration AMG.

Drug levels during the course of a dosing interval.

(A) Mean (SD) serum continuous erythropoietin receptor activator (C. E

Schematic illustration of exposure-driven response models (upper row) and biophase-driven response (bottom row). Schematic illustration of exposure-driven.

Typical response-time courses obtained after different doses and routes of administration (3 and 10 µg i.v., and 10, 50, and 100 µg s.c.). Typical response-time.

Mean plasma concentrations of ampicillin/sulbactam in plasma of critically ill patients with AKI undergoing extended dialysis (duration depicted by box.

Half-life of removal from subcutaneous administration site after subcutaneous administration of fluorescence-labeled VEGF-C156S, ovalbumin (OVA), bovine.

Fraction of dose (mean, n = 3–4) recovered in peripheral lymph following subcutaneous administration to sheep for a series of small molecular compounds.

A pilot study of equal doses of 10% IGIV given intravenously or subcutaneously Shilpa H. Desai, BS, MD, Akhil Chouksey, MD, John Poll, RN, Melvin Berger,

A loading dose decreases the time to achieve the target concentration.

Molecular Therapy - Nucleic Acids

Enrollment, outcomes, and pharmacokinetics.

(Left) Observed (symbols) and model-predicted (lines) response (tail flick) vs. time of drug X after different doses given by the intravenous (red) and.

Unbound drug concentrations in plasma (dotted) and brain ISF (solid, calculated from recovery and dialysate concentration) following repeated subcutaneous.

Synthetic oligosaccharides can replace animal-sourced low–molecular weight heparins by Yongmei Xu, Kasemsiri Chandarajoti, Xing Zhang, Vijayakanth Pagadala,

Activation and desensitization of the α7 nAChRs.

The effect of a change in the expression level of the receptor and the binding affinity on the subcutaneous bioavailability of mAbs. The effect of a change.

Mean serum concentration time profiles of anifrolumab following subcutaneous and intravenous administration of anifrolumab.a aData below the limits of.

Average trastuzumab serum concentrations in female minipigs following single subcutaneous administration of trastuzumab in formulations without and with.

Allometric relationship between the lymph flow in the thoracic duct and species body weight. Allometric relationship between the lymph flow in the thoracic.

Plasma concentration-time profile after oral administration of a single dose. Plasma concentration-time profile after oral administration of a single dose.

A change in either volume of distribution or clearance has differing effects on the concentration-time profile. A change in either volume of distribution.

Presentation transcript:

Dose-normalized plasma concentration-time curves of a mAb following subcutaneous (SC) and intravenous (IV) administration to cynomolgus monkeys (mean ± S.D., n = 3): slow absorption after SC dosing with maximum concentrations reached after 3–4 days. Dose-normalized plasma concentration-time curves of a mAb following subcutaneous (SC) and intravenous (IV) administration to cynomolgus monkeys (mean ± S.D., n = 3): slow absorption after SC dosing with maximum concentrations reached after 3–4 days. Wolfgang F. Richter, and Björn Jacobsen Drug Metab Dispos 2014;42:1881-1889 Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics